1965 Chrysler Imperial 2 Door Hardtop on 2040-cars
Dresden, Tennessee, United States
|
440 CU Engine -Power windows and seat -Dual Exhaust -Mag/Continental Wheels -Car is unique as it was originally a 4 door and shortened to be a 2 door. -New interior Any questions, please contact Dan Mason at 440-552-2127. |
Chrysler Imperial for Sale
1964 chrysler imperial crown coupe 96k miles 413 v8, leather, all power options!(US $12,900.00)
1981 chrysler imperial , 2 door coupe ,silver pqint , maroon leather seats(US $3,600.00)
- frank sinatra edition - 1 of 278 - ..how many left?(US $5,000.00)
1956 chrysler imperial 4 door sedan. project car. parts car. restoration. no eng(US $4,700.00)
1955 chrysler imperial base sedan 5.4l v8 project car. needs restoration, parts(US $3,000.00)
1931 chrysler imperial custom 8 sedan, 50,242 actual documented miles!(US $119,900.00)
Auto Services in Tennessee
Veterans Auto Services ★★★★★
Toyota Of Cool Springs ★★★★★
Sun Tech Auto Glass ★★★★★
Roger Miller`s Boat & RV Fiberglass Body Shop ★★★★★
RES Automotive ★★★★★
Quality Motors ★★★★★
Auto blog
Dodge says three new variants of the Charger and Challenger are on their way
Fri, Oct 23 2020Introduced in 2008, the current Dodge Challenger is one of the oldest new cars on the American market. It's not ready to retire, and documents published by Canadian union Unifor confirm it will remain in production until at least 2023. Better yet, the company announced it will release several new versions of the car in the coming years. Fiat-Chrysler Automobiles (FCA) narrowly avoided a costly strike by signing a new three-year agreement with Unifor, the union that represents most of its Canadian workers. It pledged to inject $1.58 billion Canadian (about $1.2 billion U.S.) into its local operations while creating 2,000 new jobs in the nation. Some of that money will be allocated to the Brampton Assembly factory located on the outskirts of Toronto, where it will be used to build three new variants of Dodge's Charger and Challenger models. Details about what the company has in store weren't included in the release, but Dodge has shown it's capable of mustering an unusually high level of creativity when it comes to keeping the Challenger and the Charger fresh. Hellcat, Demon, T/A 392, and Super Stock models have joined the range in recent years, and its efforts have paid off, as 60,997 units of the Challenger were sold in the United States in 2019. It even outsold the Camaro and the Mustang during the third quarter of the year. Annual Charger sales jumped by 21% to 96,935 units in 2019. With that said, Dodge's definition of a new variant is murky. It could be alluding to a trim level, an option package, a limited-edition model, or a face-lifted version. Regardless, we're betting they'll be exceptionally powerful. Chrysler will continue to build the 300 in Brampton through 2023, too, but there's no word on what the future has in store for the sedan. It's also relatively old, but it's not faring nearly as well as its Dodge-badged siblings. Sales fell to 29,213 units in 2019, a 37% drop compared to 2018, and the lineup was pared down for 2021. Moving west, the Windsor factory will be retooled to build plug-in hybrid and electric vehicles, and it will be assigned at least one new model, but FCA didn't reveal what it will be, or when we'll see it. Industry whisperings claim that's where the production version of the CES-friendly Chrysler Portal concept will be built.
Chrysler stays IPO until 2014
Mon, 25 Nov 2013There will not be a Chrysler IPO in 2013. Fiat, according to a report from Forbes, has announced that it will not be able to make the American brand's initial public offering before the end of the year, saying that the short, five-week window that makes up the rest of 2013 is "not practicable."
Not surprisingly, the issue with the Chrysler IPO is the same as it's always been - a disagreement between parent company Fiat, which owns 58.5 percent of the Chrysler Group and a UAW healthcare trust, which owns 41.5 percent. Fiat wants to buy out the UAW VEBA healthcare trust, which is responsible for shouldering retiree healthcare costs, but the two sides are hung up on an actual price tag for the remaining two-fifths of the company.
The original idea saw an IPO as a way of setting a fair market price for the remaining shares, although it's not entirely clear what broke down and led to a delay of the IPO plan. As Forbes points out, by waiting until 2014, Chrysler could be risking a cool-off in the IPO market, which could mean less money in its pocket when the automaker finally goes public.
Fiat Chrysler says it did not know about Marchionne's illness
Fri, Jul 27 2018ZURICH/MILAN — Fiat Chrysler said it knew nothing about the medical condition of Sergio Marchionne after a Swiss hospital said on Thursday it had been treating the deceased chief executive for more than a year. "Due to medical privacy, the company had no knowledge of the facts relating to Mr. Marchionne's health," a Fiat Chrysler spokesman said. Questions have been raised about how long Marchionne, who died on Wednesday, was ill and how much the company knew before it made the situation public. Marchionne rescued Fiat and Chrysler from bankruptcy after taking the wheel of the Italian carmaker in 2004 and he multiplied Fiat's value 11 times through 14 years of canny dealmaking. He was due to step down at FCA in April next year. "The company was made aware that Mr. Marchionne had undergone shoulder surgery and released a statement about this," the spokesperson said. "On Friday, July 20, the company was made aware with no detail by Mr. Marchionne's family of the serious deterioration in Mr. Marchionne's condition and that as a result he would be unable to return to work. The company promptly took and announced the appropriate action the following day." Asked whether the scope of the statement included the board and the chairman, the company declined to comment. In emailed comments, Marchionne's family confirmed the companies had not been aware of his health conditions. "At the end of last week FCA was made aware Sergio Marchionne would no longer be able to return to work without mentioning any further details," the family said. The announcement of the death of Marchionne, 66, one of the auto industry's most tenacious and respected CEOs, drew tributes from rivals and tears from his closest colleagues on Wednesday. University Hospital Zurich said earlier on Thursday Marchionne had been treated for a serious illness for more than a year before his death. Marchionne had fallen gravely ill after what the company had described as shoulder surgery at a Zurich hospital. He was replaced as chief executive last weekend after Fiat Chrysler (FCA) said his condition had worsened. "Mr. Sergio Marchionne was a patient at USZ. Due to serious illness, he had been the recipient of recurring treatment for more than a year," the hospital said in a statement. "Although all the options offered by cutting-edge medicine were utilized, Mr.






